Reddish rash all over body with itching its urtecaria what should we give other than tb atrax
Reading File
Finding Sources
Searching the Web
urticaria treatment guidelines antihistamines 2024
Reading File
Finding Sources
Here is a full, practical guide to managing urticaria (hives with itching) beyond hydroxyzine (Atarax):
Urticaria Management - Treatment Options Beyond Hydroxyzine (Atarax)
Step 1 - First-Line: Second-Generation (Non-Sedating) H1 Antihistamines
These are the recommended first-line treatment by all current international guidelines (updated 2026). They are preferred over hydroxyzine because they cause minimal sedation and can be dosed once daily.
| Drug | Dose (Adult) | Notes |
|---|---|---|
| Cetirizine (Zyrtec) | 10 mg once daily | Slightly sedating at higher doses |
| Loratadine (Claritin) | 10 mg once daily | Least sedating |
| Fexofenadine (Allegra) | 180 mg once daily | Truly non-sedating |
| Levocetirizine | 5 mg once daily | Active isomer of cetirizine |
| Desloratadine | 5 mg once daily | Active isomer of loratadine |
| Bilastine | 20 mg once daily | Good tolerability |
Key point: If standard dose fails, doses can be increased up to 4x the standard dose before escalating to the next step (e.g., cetirizine 40 mg/day), per current guidelines.
Step 2 - Add-On: H2 Antihistamines
About 15% of skin histamine receptors are H2 type, so adding an H2 blocker can improve response:
- Famotidine 20 mg twice daily
- Cimetidine 400 mg twice daily (older option, drug interactions)
Combine with the H1 blocker, not as monotherapy. - Rosen's Emergency Medicine
Step 3 - Refractory Acute Urticaria: Short Course Corticosteroids
For severe or refractory acute urticaria:
- Prednisolone 0.5-1 mg/kg/day orally for 3-5 days
- Not for long-term use due to side effects
Step 4 - Chronic Urticaria Unresponsive to Antihistamines: Omalizumab
- Omalizumab (Xolair) - anti-IgE monoclonal antibody
- 150 or 300 mg SC injection monthly
- Effective in ~80% of antihistamine-refractory chronic urticaria patients
- Now well-established as step 3 in international guidelines
Step 5 - Refractory Disease: Newer Biologics & Immunosuppressants
- Dupilumab - approved for chronic spontaneous urticaria unresponsive to antihistamines (2024-2026 approval)
- Ciclosporin 3-5 mg/kg/day - for severe refractory cases
- Doxepin 10-50 mg at night - tricyclic with both H1+H2 blocking activity, useful for refractory cases
For Severe/Anaphylactic Presentation
If urticaria is part of anaphylaxis (airway involvement, hypotension, angioedema):
- Epinephrine (adrenaline) IM is the treatment of choice - 0.3-0.5 mg IM into outer thigh
- Then add antihistamines and steroids as supportive therapy
Quick Summary by Severity
| Severity | Treatment |
|---|---|
| Mild acute urticaria | Cetirizine / Loratadine / Fexofenadine PO once daily |
| Moderate / not responding | Up-dose to 4x standard dose; add H2 blocker (famotidine) |
| Severe acute | Add short course prednisolone 0.5-1 mg/kg x 3-5 days |
| Chronic (>6 weeks), refractory | Omalizumab 300 mg SC monthly |
| Severe refractory chronic | Dupilumab or Ciclosporin |
| Anaphylaxis | Epinephrine IM first, then antihistamines + steroids |
Sources: Dermatology 2-Volume Set 5e (p.386), Rosen's Emergency Medicine, Harrison's Principles 22E, Fitzpatrick's Dermatology; 2026 International Urticaria Guidelines (EAACI/GA2LEN/AAD)
Hydrocort iv give
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.
This is a shared conversation. Sign in to Orris to start your own chat.